Skip to content
value.today

Neotract Inc.

🇺🇸 Pleasanton, California, USABiotechnologyFounded 2004
Total raised
$117 M
4 rounds on record
Latest round
$13 M
Dec 2016
First round on record
Jul 2009
Today
Private
No later event on record

Funding rounds

4 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Neotract Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Dec 2016$13 MNo. 4$10 to $50 million

Neotract Inc.: Raise no. 4, Dec 2016

Investors in this round

12 investors had bought by the notice of Jan 6, 2017: 12 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$13 M of $15 M offered; $2 M still to sell
Smallest investment taken
$1
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David Amerson · Executive Officer, Director
  • Frank M. Torti · Director
  • Joshua W. Makower · Director
  • Kadir W. Kadhiresan · Director
  • Robert K. Anderson · Director
  • Robert W. Croce · Director
  • Ryan W. Drant · Director
  • Theodore W. Lamson · Director
  • William M. Facteau · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by David Amerson, Chief Executive Officer. Source: SEC Form D, newest notice filed Jan 6, 2017. Read the notice at the SEC.

equitySEC
May 2012$51 MNo. 3$50 to $250 million

Neotract Inc.: Raise no. 3, May 2012

Investors in this round

71 investors had bought by the notice of Jan 28, 2014: 71 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$51 M of $57 M offered; $6 M still to sell
Smallest investment taken
$1
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David Amerson · Executive Officer, Director
  • John Nehra · Director
  • Joshua Makower · Director
  • Kadir Kadhiresan · Director
  • Robert Anderson · Director
  • Robert Croce · Director
  • Ryan Drant · Director
  • Theodore Lamson · Director
  • William Facteau · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by J. Casey McGlynn, Secretary. Source: SEC Form D and 1 amendment, newest notice filed Jan 28, 2014. Read the notice at the SEC.

equitySEC
Jan 2011$26 MNo. 2$10 to $50 million

Neotract Inc.: Raise no. 2, Jan 2011

Investors in this round

5 investors had bought by the notice of Feb 4, 2011: 5 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$26 M of $27 M offered; $1 M still to sell
Smallest investment taken
$1
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Christopher W. Rowland · Executive Officer
  • Theodore C. Lamson · Executive Officer, Director
  • John K. Nehra · Director
  • Joshua K. Makower · Director
  • Kadir K. Kadhiresan · Director
  • Maria K. Sainz · Director
  • Robert K. Anderson · Director
  • Robert W. Croce · Director
  • Ryan W. Drant · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Christopher Rowland, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Feb 4, 2011. Read the notice at the SEC.

equitySEC
Jul 2009$28 MNo. 1$10 to $50 million

Neotract Inc.: Raise no. 1, Jul 2009

Investors in this round

15 investors had bought by the notice of Oct 26, 2009: 15 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$28 M of $30 M offered; $2 M still to sell
Smallest investment taken
$1
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Theodore C. Lamson · Executive Officer, Director
  • John K. Nehra · Director
  • Joshua K. Makower · Director
  • Maria K. Sainz · Director
  • Robert K. Anderson · Director
  • Robert W. Croce · Director
  • Roger W. Guidi · Director
  • Ryan W. Drant · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Theodore C Lamson, President and Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Oct 26, 2009. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Neotract Inc. chose not to state its revenue in its newest notice of a funding round (Jan 2017).

    SEC Form D · Jan 2017

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Jan 2017

That is all the official record says: Neotract Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Neotract Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 71 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Neotract Inc.
NameRoleNamed in
David AmersonExecutive officerJan 2017
Christopher W. RowlandExecutive officerFeb 2011
Theodore C. LamsonExecutive officerFeb 2011
David AmersonDirectorJan 2017
Frank M. TortiDirectorJan 2017
Joshua W. MakowerDirectorJan 2017
Kadir W. KadhiresanDirectorJan 2017
Robert K. AndersonDirectorJan 2017
Robert W. CroceDirectorJan 2017
Ryan W. DrantDirectorJan 2017
Theodore W. LamsonDirectorJan 2017
William M. FacteauDirectorJan 2017
John NehraDirectorJan 2014
Joshua MakowerDirectorJan 2014
Kadir KadhiresanDirectorJan 2014
Robert AndersonDirectorJan 2014
Robert CroceDirectorJan 2014
Ryan DrantDirectorJan 2014
Theodore LamsonDirectorJan 2014
William FacteauDirectorJan 2014
Maria SainzDirectorMay 2012
John K. NehraDirectorFeb 2011
Joshua K. MakowerDirectorFeb 2011
Kadir K. KadhiresanDirectorFeb 2011
Maria K. SainzDirectorFeb 2011
Theodore C. LamsonDirectorFeb 2011
Roger W. GuidiDirectorOct 2009
Roger GuidiDirectorJul 2009